IVP Services

Our highly qualified in vivo pharmacology staff are uniquely positioned within our integrated drug discovery teams. This enables us to maximise multidisciplinary study support and ultimately accelerate your drug discovery efforts. 

Our experts specialise in four key areas:

CNS Disorder Models

We have a unique and extensive experience in diseases of the CNS including Psychiatric Disorders, which can be a particularly challenging field for drug development.

Metabolic Models

Our history of performing high quality in vivo pharmacology investigations in the metabolic space ranging from insulin resistance to diabetic complications means we are well equipped to guide the right choice of translatable models and necessary endpoints.

Fibrosis and Inflammation Models

We have established a range of in vivo and ex vivo pharmacology models, which enables careful assessment of drug candidates.

In Vivo Oncology Models

Our Translational Oncology team offers bespoke, high quality in vivo pharmacology services to customers.

Delivering for our customers - a proven track record

  • 48 pre-clinical candidates delivered
  • 27 already progressed to clinical trials (>50%)
  • Sygnature Discovery co-inventors named on >170 client patent applications
Performance graph only (with atom filigrane)-1

Discover your next project's potential

Animal welfare is our top priority at Sygnature Discovery. We employ the highest standards of animal care and implement the principles of the 3Rs (replacement, reduction and refinement) to all studies, and have worked hard to foster a culture of compassion and care towards all our animals.